x

Search for a networks

* (*) mandatory field

International, Multi-center, Open Label, 9-month Follow-up Extension Study Assessing the Long-term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : -
  • Sponsor : PHARNEXT SAS
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - US
  • ADDRESS: NOT PROVIDED - US
  • UNITED STATES
  • More information
  • Phone  : -
  • Fax  : -
  • Sponsor of multinational clinical trial

  • PHARNEXT SAS
  • Pharnext SAS
  • 46 Rue Saint Lazare
  • 75009 PARIS
  • FRANCE
  • More information
  • Phone  : 33 (0)1 41 09 22 30
  • Fax  : 33 (0)1 41 09 22 31
  • Website
  • Contact secretary  :
Last update: October 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.